Diagnostic method for detecting dysplastic epithelial tissue
View Patent ↗In diagnostic testing for cancer and precancer of the epithelium, the undesired binding of cancer-selective dyes to proteins in the extracellular matrix, which may lead to false positives, is reduced by applying to the epithelium being tested, before application of the dye, a solution of a non-toxic amphiphilic protein in a pharmacolgically acceptable solvent.
1. In a diagnostic method for detecting
dysplastic epithelial tissue, which diagnostic method includes the step of
topically applying a mitochondrial marking agent, which selectively stains mitochondria of cancerous and precancerous cells, to a locus of suspect tissue, said locus comprising epithelial cells and extracellular matrix, said matrix being subject to temporary staining by said agent, thereby leading to possible false positive results of said diagnostic method,
the improvement in said diagnostic method for decreasing false positive results of said method, said improvement comprising the step of inhibiting the staining of said extracellular matrix in said locus by said marking agent, by topically applying to said locus, prior to applying said marking agent to said locus, a solution of a non-toxic amphiphilic protein in a pharmacologically acceptable solvent.